Skip to content
MedsAcross

Medicine

Pyridostigmine 60 mg tablet

Available on requestPrescription onlyUS FDAGeneric name

Pyridostigmine 60 mg tablet is a generic prescription medicine for oral use, made by 7 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F).

Key facts

Active ingredient (INN)
Pyridostigmine
Brand
Sold under the generic name
Strength
60 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 500 tablets, 30 tablets and 14 more
Manufacturers
Zydus LifesciencesIndiaMethod PharmaceuticalsAmneal Pharmaceuticals of New YorkAmerican Health PackagingANI PharmaceuticalsGolden State Medical SupplyMajor Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
N07AA02 Pyridostigmine
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
24 April 2003
Identifiers
RxCUI 903857DailyMed set ID 0f56facf-1f0a-4ba5-876d-757b114dfa45, 36284496-e56e-466c-9b56-6007bb5bb699, 0a114d99-e50b-49fe-9e0f-ccce279ffb4f +5NDC 0115-3511, 0904-6622, 62559-470 +5Application ANDA040502, ANDA205650, ANDA040512 +1

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet in 1 bottle65841-819-01Zydus LifesciencesIndia7 August 2015
500 tablet in 1 bottle65841-819-05Zydus LifesciencesIndia7 August 2015
30 tablet in 1 bottle65841-819-06Zydus LifesciencesIndia7 August 2015
90 tablet in 1 bottle65841-819-16Zydus LifesciencesIndia7 August 2015
100 tablet in 1 bottle68382-659-01Zydus LifesciencesIndia7 August 2015
500 tablet in 1 bottle68382-659-05Zydus LifesciencesIndia7 August 2015
30 tablet in 1 bottle68382-659-06Zydus LifesciencesIndia7 August 2015
90 tablet in 1 bottle68382-659-16Zydus LifesciencesIndia7 August 2015
100 tablet in 1 bottle0115-3511-01Amneal Pharmaceuticals of New York24 April 2003
500 tablet in 1 bottle0115-3511-02Amneal Pharmaceuticals of New York24 April 2003
100 tablet in 1 bottle62559-470-01ANI Pharmaceuticals16 January 2024
100 tablet in 1 bottle58657-811-01Method Pharmaceuticals15 June 2024
30 tablet in 1 bottle58657-811-30Method Pharmaceuticals15 June 2024
90 tablet in 1 bottle58657-811-90Method Pharmaceuticals15 June 2024
100 blister pack in 1 box, unit-dose / 1 tablet in 1 blister pack68084-494-01American Health Packaging4 October 2011
30 tablet in 1 bottle51407-590-30Golden State Medical Supply25 September 2024
100 blister pack in 1 carton / 1 tablet in 1 blister pack0904-6622-61Major Pharmaceuticals7 August 2015

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 6 April 1955Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Pyridostigmine 60 mg tablet.

Compare 1

Other strengths and forms of Pyridostigmine

Clinical summary

Pyridostigmine is a cholinesterase inhibitor. It is available as tablets, oral solution and extended-release tablets for intravenous and parenteral use. MedsAcross supplies Pyridostigmine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Pyridostigmine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Pyridostigmine 60 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.